PDF
File
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
After the treating veterinarian at Evidensia Specialist Animal Hospital Helsingborg carried out the last follow-up of the dog that was treated in the autumn of 2021, a very good clinical result can be confirmed.
During the late summer, the Company's subsidiary within Animal Care began a collaboration with Evidensia Specialist Animal Hospital Helsingborg, where vetIQure™ with its Tumour Specific Electroporation technology (TSE) is currently being evaluated on both small animals and horses.
"A dog with a giant cell tumour in the palate has been treated with a positive outcome. It was a very difficult-to-treat tumour that has not responded to other types of treatment. After a successful treatment with TSE, follow-up tests now show that no tumour cells remain in the area." - says treating veterinarian Majbritt Larsen at Evidensia Specialist Animal Hospital Helsingborg.
"It is fantastic to hear that the benefits of TSE also demonstrate a complete tumour response in veterinary medicine as well. The results and feedback naturally affect our opportunities for commercial success in our Animal Care business area." - says CEO Mohan Frick